Is pulse pressure a predictor of new-onset diabetes in high-risk hypertensive patients?: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial.
Is pulse pressure a predictor of new-onset diabetes in high-risk hypertensive patients?: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial.
复制标题
DOI:
10.2337/dc09-1447
复制
发表时间:
2010-05
期刊:
影响因子:
16.2
通讯作者:
Nakao K
中科院分区:
文献类型:
--
作者:
Yasuno S;Ueshima K;Oba K;Fujimoto A;Hirata M;Ogihara T;Saruta T;Nakao K
Hypertensive patients have an increased risk of developing diabetes. Accumulating evidence suggests a close relation between metabolic disturbance and increased arterial stiffness. Here, we examined the association between pulse pressure and the risk of new-onset diabetes in high-risk Japanese hypertensive patients. The Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial examined the effects of candesartan and amlodipine on the incidence of cardiovascular events in 4,728 high-risk Japanese hypertensive patients. In the present study, we analyzed the relationship between pulse pressure at baseline and new-onset diabetes in 2,685 patients without diabetes at baseline (male 1,471; mean age 63.7 years; mean BMI 24.8 kg/m2) as a subanalysis of the CASE-J trial. During 3.3 ± 0.8 years of follow-up, 97 patients (3.6%) developed diabetes. In multiple Cox regression analysis, pulse pressure was an independent predictor for new-onset diabetes (hazard ratio [HR] per 1 SD increase 1.44 [95% CI 1.15–1.79]) as were male sex, BMI, and additional use of diuretics, whereas age and heart rate were not. Plots of HRs for new-onset diabetes considering both systolic and diastolic blood pressure (DBP) revealed that a higher pulse pressure with a lower DBP, indicating that the increased pulse pressure was largely due to increased arterial stiffness, was strongly associated with the risk of new-onset diabetes. Pulse pressure is an independent predictor of new-onset diabetes in high-risk Japanese hypertensive patients. Increased arterial stiffness may be involved in the development of diabetes.
登录
查看更多内容
影响因子:
5.4
作者:
Fukui, T;Rahman, M;Fukiyama, K
通讯作者:
Fukiyama, K
影响因子:
8.3
作者:
Alderman, MH;Cohen, H;Madhavan, S
通讯作者:
Madhavan, S
影响因子:
8.3
作者:
Verdecchia, P;Reboldi, G;Porcellati, C
通讯作者:
Porcellati, C
影响因子:
16.2
作者:
Gupta, Ajay K.;Dahlof, Bjorn;Poulter, N. R.
通讯作者:
Poulter, N. R.
影响因子:
8.3
作者:
Malik, A. Rauoof;Kondragunta, Venkateswarlu;Kullo, Iftikhar J.
通讯作者:
Kullo, Iftikhar J.